GT Biopharma, Inc. (GTBP) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2010: $5.65M2011: $5.23M2012: $6.56M2013: $6.48M2014: $30.46M2015: $50.62M2016: $18.95M2017: $2.68M2018: $14.03M2019: $19.71M2021: $10.26M2022: $5.00M2023: $6.63M2025: $1.32M$1.32M
2010Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$1.32M
2023$6.63M+32.6%
2022$5.00M-51.2%
2021$10.26M
2019$19.71M+40.5%
2018$14.03M+423.7%
2017$2.68M-85.9%
2016$18.95M-62.6%
2015$50.62M+66.2%
2014$30.46M+370.0%
2013$6.48M-1.2%
2012$6.56M+25.5%
2011$5.23M-7.5%
2010$5.65M